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Abstract 
Glycine-serine interconversion is important to numerous metabolic processes and serine release by the kidney. Incubation of freshly 
isolated rat renal proximal tubules with 5 mM glycine 75% 13C-labelled in the 2-position resulted in J3C-labelled incorporation i to serine 
of 69 p, mol.g protein -t (+ 14, n = 16) at 20 min. Addition of 5 mM glucose, 4 mM lactate, 1 mM alanine, 1 mM butyrate and 1 mM 
glutamate increased ~3C-label incorporation i to serine to 173 /zmol.g protein -1 (+32, n = 4) at 60 min, 50% greater than tubules 
incubated with 5 mM glycine alone (P < 0.05). The increase was prevented by hypoxia. Reoxygenation for 20 min restored the rate of 
incorporation of 13C-label into serine. The fraction of unlabelled serine remained ~ 47% at 20, 40 and 60 min in each group. The results 
indicate that in the presence of oxygen, TCA and glycolytic intermediates stimulate serine synthesis via the glycine cleavage complex and 
serine hydroxymethyltransferase p thways and not the phosphorylated pathway. In addition, significant serine production occurs from an 
unidentified source, which is ~lso tightly coupled to glycine metabolism. Both in the presence and absence of added TCA and glycolytic 
intermediates, glycine was the principle source of the methylene group in methylene t trahydrofolate. 
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1. Introduction 
Serine availability is highly dependent on renal serine 
production, which contributes the equivalent of dietary 
serine uptake in man and approximately half the dietary 
uptake in the rat [1]. Net uptake of glycine and release of 
serine occurs into the renal circulation. Glycine-serine 
interchange is stimulated by acidosis and during starvation, 
which suggests a significant central role for glycine as an 
alternative and regulatable donor of NH~- for renal acid 
excretion [2]. Intracellular glycine-serine interconversion 
contributes to the regeneration of substituted tetrahydrofo- 
late (THF) by the formation of 5,10-methylene-THF (m- 
THF) essential for numerous metabolic processes. Despite 
the amount of serine formed by the kidney and recent 
interest in glycine-serine rrtetabolism because of glycine's 
protective role in hypoxic injury to proximal tubules, the 
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sources of serine released into the renal vein remain 
uncertain. 
The two major known pathways of serine formation are 
firstly, from glycine via the combined action of the glycine 
cleavage complex (GC) and serine hydroxymethyltrans- 
ferase (SHMT) and secondly, from the gluconeogenic 
intermediate 3-phosphoglycerate via the phosphorylated 
pathway (Fig. 1). Catabolism of serine is believed to occur 
via the non-phosphorylated pathway, enabling gluconeo- 
genesis from serine [3], as demonstrated by numerous 
studies investigating control of hepatic serine metabolism 
[4-6]. 
The relative contribution of precursors via several 
metabolic pathways to serine production, is influenced by 
the availability of the precursors and the activity of the 
enzymatic pathways. Using arteriovenous difference mea- 
surements across the kidney, Brosnan proposed that glycine 
uptake only contributed 15-30% of serine production [2]. 
The phosphorylated pathway [2], proteolysis and peptide 
cleavage [1] were suggested to be the additional sources of 
renal serine. However, measurement of arteriovenous dif- 
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ferences only determines the net production or consump- 
tion across an organ. In the kidney, which has extensive 
structural and metabolic heterogeneity, arteriovenous dif- 
ferences may not reflect he availability of substrates within 
the kidney. This point was demonstrated in studies where 
glycine utilisation via the glycine cleavage complex was 
inhibited by adding cysteamine, glycine release was twice 
the rate of glycine uptake in the absence of cysteamine [7]. 
This suggests that glycine availability in renal cells is at 
least twice that indicated by the net arteriovenous differ- 
ence. 
Various and sometimes conflicting accounts of sub- 
strates for serine synthesis have been reported. For exam- 
ple, early work in vivo investigating the contributions of 
glucose, glycerol, glutamate, glutamine and glycine to 
serine formation detected only ~4C incorporation i to ser- 
ine from glycine [8]. In contrast, serine formation was 
increased in isolated cortical tubules by addition of either 
glycine, aspartate, glutamate or glutamine [9]. However, 
glucose, lactate, pyruvate, pyruvate plus ammonia and 
alanine did not increase serine formation [9]. Serine forma- 
tion from glycine and aspartate was reduced by inhibition 
of GC (cysteamine) and phosphoenolpyruvate carboxyki- 
nase (mercaptopicolinic a id) respectively [7]. Serine re- 
lease was increased in isolated perfused rat kidneys by 
addition of aspartate or glutamate, with incorporation of 
14C label into serine from aspartate also reported [10]. 
Incubation of cortical tubules with ~3C-labelled glutamate 
did not form labelled serine despite formation of labelled 
glucose [11]. In general, the studies demonstrate potential 
for serine formation from phosphorylated pathway precur- 
sors when added in isolation. However, glycine appears to 
be the primary and preferred source of serine. These 
controversies could be resolved if the source of serine 
could be identified when precursors of both the phospho- 
rylated pathway and GC and SHMT are added simultane- 
ously. 
We recently used 13C-NMR serine isotopomer analysis 
of [2-13C]serine, [3-13 C]serine and [2,3-13C]serine formed 
from incubating freshly isolated rat renal proximal tubules 
with [2-13 C]glycine to determine the 13C-labelled fractions 
of glycine (Fgly) and the methylene group in m-THF (F m) 
available for serine formation [12]. These allowed calcula- 
tion of the fraction of m-THF derived from glycine via GC 
[12]. Gas chromatography-mass spectroscopy (GC-MS) of 
the glycine and serine in these samples complemented the 
13C-NMR results, allowing 13C-enrichment of glycine and 
serine to be determined. These methods allowed the rela- 
tive forward and reverse rates of SHMT and GC to be 
approximated and independent formation of unlabelled 
serine and glycine to be identified in situ [12]. Rapid 
unlabelled glycine formation early in the incubation ac- 
counted for ~ 5-10% of total glycine. Interestingly ~ 
50% of the serine formed was unlabelled, even when 
100% 13C-labelled glycine was the only substrate [12]. 
In this study using freshly isolated rat proximal tubules, 
we investigated serine formation from unlabelled sub- 
strates with the potential to compete with labelled glycine 
by monitoring changes in the fraction of ~3C-labelled 
serine by 13 C-NMR serine isotopomer analysis and GC-MS. 
This allowed the simultaneous investigation i situ of the 
role of glycolytic, gluconeogenic and TCA intermediates 
(via the phosphorylated pathway) to serine formation, in 
addition to active serine formation from glycine via SHMT 
and GC. The relative contributions of precursors of both 
the phosphorylated pathway and GC and SHMT to m-THF 
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Fig. 1. Metabolic pathway for glycine and serine synthesis. A pathway for possible NH~ utilisation is indicated by the broken lines. This is suggested as 
the mechanism for the observed stimulation of glycine cleavage complex by TCA and glycolytic intermediates (see Section 4). 
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formation were estimated. The experiments were per- 
formed both under normoxic conditions and under nor- 
moxia followed by hypoxia and reoxygenation. 
2. Materials and methods 
2.1. Experimental procedure 
Kidneys from male Wistar rats weighing 400-550 g 
with free access to water and fed ad libitum with rat and 
mouse cubes (NORCO, Lismore, NSW, Australia) were 
used in all experiments. "lTae rats were anaesthetised with 
pentobarbitone sodium (60 mg/kg, i.p.). Proximal tubules 
were isolated and purified as described recently [12]. 
Incubation was commenced by adding freshly isolated 
proximal tubules to 45 ml of medium in a screw top 
conical flask, which was top gassed with 95%OJ5%CO 2 
(O2/CO 2) at 4 1/min for 4 min in a shaking water bath at 
37°C and sealed. Samples were taken at 0, 20, 40, 60 rain 
for assay of protein and LDH and 10 ml samples were 
taken at 20, 40 and 60 rain for ~3C-NMR. The samples 
were snap-frozen in liquid N 2 and stored at -70°C. 
Samples were extracted width perchloric acid (PCA) for 13C 
NMR analysis as described below. Groups 1 and 2 were 
normoxic experiments gas.sed with O2/CO 2 at 0, 20 and 
40 min and contained 5 mM glycine 75% [2-13 C]glycine 
(C /D/N  Isotopes, Quebec, Canada) alone or with the 
addition of 5 mM glucose, 4 mM lactate, 1 mM alanine, 1 
mM glutamate and 1 mM butyric acid respectively. Groups 
3 and 4 were gassed with 95%N2/5%CO 2 at 20 min then 
regassed with O2/CO 2 at 40 min with the same medium 
as groups l and 2 respectively. Each experiment was 
repeated four times. 
2.2. Tubule integrity 
Tubule cell integrity was assessed by measuring the 
release of lactate dehydrogenase (LDH) into the incubation 
medium. LDH was assayed after Bergmeyer [13] and 
expressed as the percent of activity in the supernatant 
relative to the total sample following addition of Triton 
X-100. The fraction of viable cells was assumed to equal 
(100 - %LDH released)/100. 
measurement, 3 ml of the supernatant from the rediluted 
lyophilised sample was used with 150 pA of 1.8 M tetram- 
ethylsilylpropanoic a id (TSP, MSD Isotopes, Montreal, 
Canada) as an internal reference; samples were adjusted to 
pH 6.8. Partially relaxed proton decoupled 13C-NMR spec- 
tra were acquired at 300 K using a Bruker AMX500 
spectrometer. The same acquisition parameters were used 
as described previously [12], with a repetition interval of 2 
s and 7/zs pulse length (45°). 
Serine isotopomer analysis has been previously de- 
scribed in detail [12]. Briefly, Fg~ was calculated from 
[2,3-13C]serine/([2,3-13C]serine + (3-13C]serine) and F m 
from [2,3-13C]serine/([2,3-~3C]serine + [2-13C]serine). 
The fraction of m-THF derived from glycine via GC, 
Fm~c ), was calculated from Fro/Ugly. Peak intensities were 
determined using deconvolution as previously described 
[12]. Glycine and serine concentrations were estimated by 
comparison of peak/TSP values with standard curves [12]. 
The amount of ~3C-labelled serine formed was calculated 
from the sum of the concentrations of [2-13 C]serine, [3- 
13C]serine plus the average of the 2-carbon and 3-carbon 
doublets. 
2.5. GC-MS analysis of 13C enrichment of serine 
Serine 13C enrichment was performed using a Hewlett- 
Packard 5840 gas chromatography unit as previously de- 
scribed [12]. Ions of mass 246.1 and 247.1 were monitored 
for glycine and ions of mass 390.2, 391.2 and 392.2 were 
monitored for serine. 
2.6. Statistical methods 
Results are expressed as mean ___ S.D. Repeated mea- 
sures analysis of variance (ANOVA) was applied to the 
data to determine if trends existed between groups, with 
time or if the trends with time differ between groups. 
Where significant differences were found, the means were 
compared by Student's t-test using the Bonferroni correc- 
tion. A difference probability of P < 0.05 was accepted as 
significant. 
3. Results 
2.3. Protein determination 
Protein was measured by a modification [14] of the 
method of Lowry [15]. BSA was used as the protein 
standard. 
2.4. NMR sample preparation and isotopomer analysis 
Samples were weighed and placed on ice and extracted 
with 12% PCA as described previously [12]. For NMR 
3.1. Proximal tubule viability 
Tubule viability was retained during preparation and 
incubation as indicated by low initial levels of LDH 
release and moderate increases with time. Differences with 
time between individual mean LDH values were not seen 
until 60 min (Fig. 2). The rate of increase and the extent of 
LDH release was the same for all groups. In these experi- 
ments LDH release was correlated (r = 0.626, n = 48, 
P < 0.01) with 13C-labelled serine formation, suggesting 
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Fig. 2. Proximal tubule viability. Open bars, glycine as only substrate, 
normoxia; cross-hatched bars, glycine with added substrates, normoxia; 
shaded bars, glycine as only substrate with hypoxia 20-40 min; solid 
bars, glycine with added substrates with hypoxia 20-40 min. n = 4 per 
group. Significance within groups: aP < 0.05, aaP < 0.01 compared to 
the 40-min time point, bP < 0.05, bbP < 0.01 compared to the 20-min 
time point, cP  < 0.05, ccP < 0.01 compared to the 0-min time point. 
that cell injury is related to metabolic activity. Damage 
from 20 min hypoxia appears to have been restricted by 
the protective action of glycine against hypoxic injury as 
previously shown in isolated proximal tubules [16]. 
3.2. Serine formation 
13C-label incorporation i to serine was 69 _ 14/zmol • g 
protein-l (average + S.D. of all four groups). Incorpora- 
tion of label into serine increased to 129 ~mol • g protein-l 
(P  < 0.05) at 40 min in the presence of substrates and 
normoxia (cross-hatched, Fig. 3) and significantly in all 
groups by 60 min. The rate of ]3C-label incorporation i to 
serine differed between the groups (P  < 0.05). Whereas 
additional substrates increased serine formation from la- 
belled glycine during 40 min of normoxic incubation, 
hypoxia between 20 and 40 min prevented this increase 
(P < 0.05, solid bars, Fig. 3). Reoxygenation led to recov- 
,50] 
150 1 b 
100 
5O 
0 
20 40 60 
Incubation Time (min) 
Fig. 3. Incorporation of 13C into serine. Open bars, glycine as only 
substrate, normoxia; cross-hatched bars, glycine with added substrates, 
normoxia; shaded bars, glycine as only substrate, hypoxia 20-40 min; 
solid bars, glycine with added substrates, hypoxia 20-40 min. n = 4 per 
group. Significance between groups: * P < 0.05 between groups with and 
without additional substrates atthe same time point. + P < 0.05 between 
normoxia nd hypoxia groups at the same time point. Significance within 
groups: aP  <0.05, aaP <0.01 compared to the 40-min time point. 
bP < 0.05, bbP < 0.01 compared to the 20-min time point. 
Table 1 
GC-MS analysis of 13C enrichment of serine 
Experimentgroup Incubation time (min) 
20 40 60 
Glycine, normoxia 48.6+ 1.9 48.1 5:1.6 48.2+ 1.4 
Glycine, normoxia 47.2 5:0.5 46.3 5:0.7 46.5 5:0.7 
plus added substrates 
Glycine, hypoxia 47.5 ___ 1.6 46.6 _+ 1.1 47.9 -t- 1.5 
Glycine, hypoxia plus 46.5 5:1.0 47.0 5:1.2 47.2 5:1.1 
added substrates 
Unlabelled serine as a fraction of total serine (T3C-labelled plus unla- 
belled, i.e., 12C-labelled) determined by GC-MS. Freshly purified rat 
proximal tubules were incubated with 75% t3C-labelled glycine (n = 4, 
mean% 5: S.D.). 
cry of serine formation and there was no significant differ- 
ence between these 2 groups at 60 min. These data indicate 
that stimulation of GC and SHMT by the additional sub- 
strates to increase labelled serine formation was oxygen- 
dependent. No significant impairment of this pathway was 
caused by a limited period of hypoxia. 
The fraction of unlabelled serine determined by GC-MS 
was approx. 47% (Table 1). There was no change with 
time or with the addition of substrates and/or hypoxia. 
Comparison of the consistency of fraction of unlabelled 
serine (Table 1) with the absolute increase in total 13C- 
labelled serine (Fig. 3) indicates that unlabelled serine 
formation increased in parallel to 13C-labelled serine. The 
rate of unlabelled serine formation therefore quals the rate 
of GC-SHMT formation of 13C-labelled serine under con- 
ditions of substrate depletion and addition and hypoxia. 
3.3. Glycine utilisation and formation 
The fraction of 13C-labelled glycine decreased from the 
initial 75% added to 70.6 + 1.2% (n = 16, 13C-NMR) and 
to 71.7 __+ 0.7% (n = 16, GC-MS) at 20 min. Thereafter, 
13C-labelling of glycine did not change with time and was 
the same in each group, determined with Fgly by 13C-NMR 
13 (Fig. 4) and 13C atom percent enrichment (C -APE)  by 
GC-MS (Table 2). Combined glycine 13C-APE results 
Table 2 
13 . C-enrichment of glycme determined by GC-MS 
Experiment group Incubation time (min) 
20 40 60 
glycine, normoxia 71.56 + 0.60 70.59 5:1.04 69.56 5:1.09 
glycine, normoxia plus 67.74 + 8.0 70.73 5:0.93 69.85 5:1.01 
added substrates 
glycine, hypoxia 72.125:0.60 71.36+0.21 70.675:0.72 
glycine, hypoxia plus 71.43 5:0.73 70.61 + 0.67 69.74 5:0.89 
added substrates 
~3C-labelled glycine as a fraction of total 13C-labelled plus unlabelled, 
i.e., 12C-labelled, glycine determined by GC-MS. Proximal tubules were 
incubated with 75% ]3C-labelled glycine (n = 4, mean% + S.D.). 
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fraction of m-THF derived from glycine via GC decreased 
significantly by 60 min in each group except with nor- 
moxia and glycine alone (P  = 0.06, Fig. 4). Hypoxia with 
additional substrates decreased Fm(~C ) by 40 min (P  < 
0.05). Therefore, glycine was the major source of the 
methylene group in m-THF in this preparation. However, 
there was an additional and constant source of methylene 
groups during incubation. 
8O 
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Fig. 4. ]3C-NMR serine isotopomer data. Open bars, glycine as only 
substrate, normoxia; cross-hatched bars, glycine with added substrates, 
normoxia; shaded bars, glycine as only substrate, hypoxia 20-40 min; 
solid bars, glycine with added s~abstrates, hypoxia 20-40 min. n = 4 per 
group. Significance b tween groups aP < 0.05, aaP < 0.01 compared to 
the 40-min time point, bP < 0.05, bbP < 0.01 compared tothe 20-min 
time point. 
were greater than combined Ugly results at 20 and 40 min 
(P  < 0.05) but not at 60 rain. 
3.4. Methylene tetrahydrofolate 
The fraction of ~3C-labelled m-THF decreased from 
69.9 _ 1.2% (n = 16) at 20 min to 66.5 _+ 1.4% (n = 16, 
P < 0.05) at 40 min and to 64.8 _ 1.2% (n = 16, P < 0.05) 
at 60 min. Within the groups, significant decreases oc- 
curred by 40 min in hypoxic groups with and without 
additional substrates and by 60 min with normoxia and 
glycine alone (Fig. 4). There were no differences between 
the extent of decrease between the groups or rate of 
decrease within each group. 
The fraction of m-THF derived from glycine (shown in 
Fig. 4, lowest panel) was 99.6 + 4.2 (n = 16) at 20 min 
and decreased to 95.4 + 2.4 (n = 16, P < 0.05) at 40 min 
and to 93.6_1.5 (n= 16, P<0.05)  at 60 min. The 
4. Discussion 
This study demonstrated that, in freshly isolated proxi- 
mal tubules from rats maintained on a normal diet, the 
phosphorylated pathway was not a major source of serine. 
However, TCA and glycolytic intermediates stimulated 
serine formation from glycine when oxygen was present. 
In the presence and absence of additional substrates, for- 
mation of unlabelled glycine reduced the ~3C-labelled frac- 
tion available for serine formation from 75% to 70% 
despite the presence of 5 mM 75% 13C-labelled glycine. 
Following 20 rain incubation, over 50% of serine was 
unlabelled (GC-MS), independent of the additional unla- 
belled substrates (Table 1). Similar values have been re- 
ported for rabbit renal proximal tubules incubated with 2 
mM 13C-glycine plus 5 mM glucose, 4.5 mM sodium 
lactate, 1 mM alanine, and 10 mM sodium butyrate anal- 
ysed by GC-MS [16]. The lengthy preparation procedure 
and washes just prior to incubation would remove unla- 
belled amino acids from the proximal tubules in our 
preparation. This suggests that unlabelled serine formation 
was not derived from the free unlabelled substrates added 
in these studies. The fraction of unlabelled serine remained 
constant and near 50% throughout the incubation period, 
and was not effected by increased labelled serine forma- 
tion. This suggests that unlabelled serine formation was 
equivalent to and coupled in some way to the rate of serine 
formation via GC and SHMT. Proteolysis and peptide 
cleavage are likely sources for the unlabelled glycine and 
serine [12]. The correlation between the labelled serine 
formation and cellular damage supports the suggestion of 
unlabelled serine formation from proteolysis. 
This study is unique in determining the contributions of 
either the phosphorylated pathway or GC and SHMT to 
serine formation, when precursors of both pathways were 
added simultaneously. Serine formation by the phospho- 
rylated pathway from the glycotytic and TCA intermedi- 
ates did not compete with serine formation from ]3C- 
labelled glycine, since the unlabelled serine fraction did 
not alter in the presence of these substrates. Previous 
conflicting results reported increased serine formation from 
aspartate, glutamate or glutamine but not glucose, lactate, 
pyruvate, or alanine [9]. These may be a consequence of 
adding a single substrate to each preparation and forcing 
the utilisation of substrates by the phosphorylated pathway, 
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which does not appear to be normally required for serine 
formation. Inhibition of GC (cysteamine) and phospho- 
enolpyruvate carboxykinase (mercaptopicolinic acid) re- 
duced serine from either glycine or aspartate respectively 
[7]. However, when glycine and aspartate were added 
together, mercaptopicolinic a id did not significantly re- 
duce serine formation. Increased serine formation from 
glycine under the conditions was proposed to explain this 
observation [7]. These results are consistent with stimula- 
tion of serine formation from other pathways, e.g., from 
glycine (Fig. 3), by glutamate, glutamine and aspartate 
rather than direct serine formation from these precursors. 
Incorporation of label into renal serine have given conflict- 
ing results. Serine was not labelled in kidneys infused in 
vivo with [U-14C]glutamate or [U-14C]glutamine [8], or 
from ~3C-labelled glutamate in cortical tubules despite 
formation of ~3C-labelled glucose [11]. However, serine 
was labelled following addition of 14C-labelled aspartate to 
isolated perfused kidneys [10]. Therefore, it appears that 
serine may only be formed by the phosphorylated pathway 
in the absence of glycine. 
The mechanism for stimulation of GC and SHMT by 
TCA and glycolytic intermediates in this study and re- 
ported previously by lactate [9] and possibly aspartate [7] 
has not been addressed. The stimulation by the additional 
substrates in this study was dependent on available oxy- 
gen. This suggests that increased oxidative metabolic activ- 
ity by the tubules stimulates GC and SHMT activity. The 
reported oxygen dependence of GC activity is consistent 
with this explanation [17]. In addition to a general increase 
in cellular metabolic activity, we hypothesise that GC was 
stimulated by removal of ammonium by the urea cycle 
(Fig. 1) increasing m-THF formation and glycine utilisa- 
tion. Uptake of ammonium by the urea cycle occurs by 
carbamoyl phosphate formation via the action of car- 
bamoyl phosphate synthetase I. This reaction requires 
2ATP, therefore increased oxidative metabolism, as in this 
study, would have increased ATP availability stimulating 
the urea cycle. Despite a less active urea cycle in the 
kidney relative to the liver [18], the localisation of the urea 
cycle on the mitochondrial membrane [18-20] with GC 
located within the mitochondria [21,22] suggests possible 
interaction. In addition, arginine synthesis by the urea 
cycle has been shown to be inhibited by removal of lactate 
from the incubation medium and increased by the addition 
of aspartate, glutamate or glutamine [23]. These substrates 
have similar effects on serine formation from glycine as 
mentioned. Therefore, both the location and regulation of 
urea cycle turnover suggest hat by increasing mitochon- 
drial ammonium utilisation, glycine utilisation and m-THF 
formation by GC are increased, stimulating serine forma- 
tion from glycine. 
Our observations of m-THF formation are consistent 
with this explanation. Serine isotopomer analysis allows 
the calculation of the fraction of 13C-labelled m-THF, 
despite m-THF not being able to be measured irectly. 
Therefore, the ability of added substrates to compete with 
glycine as the source of carbon units for m-THF can be 
determined. Glycine was the major source of mitochon- 
drial m-THF in this study (Fig. 4). An endogenous source 
of the methylene group in m-THF is indicated by the 
decrease in F m with time. However, since additional sub- 
strates did not increase unlabelled m-THF formation, the 
phosphorylated pathway does not appear to a major source 
of single carbon units in the mitochondria for m-THF in 
rat proximal tubules when glycine is available. 
In summary, serine isotopomer analysis by 13C NMR in 
combination with GC-MS has enabled independent assess- 
ment of glycine and phosphorylated pathway precursors to 
serine formation when added simultaneously. The 
phosphorylated pathway was not a major source of serine 
in the presence of glycine in renal proximal tubules iso- 
lated from rats maintained on normal dietary protein con- 
centrations. Glycine was demonstrated to be the principle 
source of serine and Cl-donor for m-THF utilised by 
SHMT for serine formation. Addition of TCA and gly- 
colytic intermediates produced an oxygen-dependent i -
crease in serine formation from glycine. We propose that 
TCA and glycolytic substrates increase serine formation by 
stimulating oxidative metabolism and urea cycle activity . 
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